AAD
Author: Willhemenia Loremipsum Special session: Lorem ipsum dolor sit amet Category: Lorem ipsum View all results

Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Chemical Peels, Microneedling, Platelet Rich Plasma in Melasma: Best Practices

Description

The discussion focuses on best practices for treating melasma using chemical peels, microneedling, and platelet-rich plasma (PRP), highlighting their efficacy and application in dermatology, especially in darker-skinned individuals. Melasma, a common hyperpigmentation issue, often requires long-term treatment and various modalities for effective management. Chemical peels are a key second-line treatment that facilitates the removal of melanin through controlled epidermal destruction. Superficial peels like glycolic and salicylic acid are recommended, while deeper peels pose risks for darker skin. Microneedling, a minimally invasive technique, enhances collagen production and is often combined with topical treatments such as PRP or tranexamic acid for improved results. PRP, derived from the patient's blood, is rich in growth factors and promotes skin regeneration, showing promise as an adjunct treatment. The session emphasizes the importance of proper patient selection, counseling, and the need for further research to refine these techniques and establish standardized protocols. Overall, an integrated approach utilizing these therapies may lead to better outcomes in melasma treatment.

View more

Conclusions

  • Melasma is a common hyperpigmentary disorder that is difficult to treat effectively over the long term.
  • Chemical peels are an effective treatment option for melasma, particularly as second-line agents or monotherapy for milder cases.
  • Superficial chemical peels are considered safest for individuals with darker skin tones.
  • Glycolic acid has the most robust evidence supporting its use in the treatment of melasma.
  • Chemical peels generally demonstrate good tolerance with minimal side effects.
  • Microneedling enhances the effectiveness of topical treatments for melasma and shows promising safety and tolerability.
  • Platelet Rich Plasma (PRP) therapy has potential as a treatment for melasma, but further studies are needed to standardize protocols and evaluate long-term efficacy.
  • Combination therapies, including topical treatments, chemical peels, microneedling, and PRP, provide a comprehensive approach to managing melasma.
  • Individualized treatment plans involving patient selection and counseling are essential for optimal outcomes in melasma management.
  • Sarkar R, Arsiwala S, Dubey N, Sonthalia S, Das A, Arya L, Gokhale N, Torsekar RG, Somani VK, Majid M, Godse K, Ravichandran G, Singh M, Aurangabadkar S, Salim T, Shah S, Sinha S. Chemical Peels in Melasma: A Review with Consensus Recommendations by Indian Pigmentary Expert Group. Indian J Dermatol. 2017 Nov-Dec;62(6):578-584. doi: 10.4103/ijd.IJD_490_17.
  • Sarkar R, Kaur C, Bhalla M, Kanwar A. The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark-skinned patients: A comparative study. Dermatologic Surgery. 2002 Sep;28(9):828-832.
  • Kumari R, Thappa DM. Comparative study of trichloroacetic acid versus glycolic acid chemical peels in the treatment of melasma. Indian J Dermatol Venereol Leprol. 2010;76:447.
  • Sarkar R, Garg V, Bansal S, Sethi S, Gupta C. Comparative Evaluation of Efficacy and Tolerability of Glycolic Acid, Salicylic Mandelic Acid, and Phytic Acid Combination Peels in Melasma. Dermatol Surg. 2016 Mar;42(3):384-391.
  • Sarkar R, Lakhani R. Chemical Peels for Melasma: A Systematic Review. Dermatologic Surgery. 2024 Jul;50(7):656-661.
  • Tuknayat A, Bhalla M, Thami GP. Platelet-rich plasma is a promising therapy for melasma. J Cosmet Dermatol. 2021;20:2431-2436.
  • Sirithanabadeekul P, Dannarongchai A, Suwanchinda A. Platelet-rich plasma treatment for melasma: A pilot study. J Cosmet Dermatol. 2019;00:1-7.
  • Eman R. M. Hofny, Amira A. Abdel-Motaleb, Alaa Ghazally, Asmaa Mahmoud Ahmed & Mahmoud R. Hussein. Platelet rich plasma is a useful therapeutic option in Melasma. Journal of Dermatological Treatment. DOI: 10.1080/09546634.2018.1524821.
  • Bikash C, Sarkar R, Relhan V, Singh S. Role of platelet-rich plasma therapy as an adjuvant in treatment of melasma. Dermatol Surg. 2022;48:429-434.